February 2018 Edition Vol.11, Issue 2

Featured Articles

February 2018Edition

As only the second medical oncologist elected as president in its history, Dr. Barbara McAneny will be in a unique position to lead the American Medical Association (AMA). We spoke to her about her future mission at the AMA, and other hot topics impa...

Moffitt Cancer Center is transitioning from clinical trials with Yescarta (axicabtagene ciloleucel) to delivery of the commercial product. Dr. Frederick Locke has been instrumental in both settings, including reimbursement, and has some thoughts on t...

There has been so much clinical progress in hematologic malignancies, thanks in part to The Leukemia and Lymphoma Society. Their President and CEO, Dr. Louis DeGennaro, tells us about the priorities for LLS in 2018....

The president of the American Association for Cancer Research (AACR), Dr. Michael Caligiuri, just became the president and physician-in-chief at the City of Hope. Dr. Caligiuri helps us look into the future by discussing topics such as precision medi...

As the article states, "the future is now" regarding precision medicine in oncology. Heck, 87% of oncology products in development are targeted. This article will help you embrace this exciting field of cancer research and development....